[Experimental systemic enzyme therapy of gouty and primary glomerulonephritis]

Eksp Klin Farmakol. Jul-Aug 2003;66(4):32-5.
[Article in Russian]

Abstract

The influence of a systemic enzymotherapy on the morphological, biochemical, and functional manifestations of the kidney damage during the experimental gouty and primary glomerulonephritis is described in comparison to the results obtained by traditional methods.

Publication types

  • English Abstract

MeSH terms

  • Allopurinol / therapeutic use
  • Animals
  • Chronic Disease
  • Cyclophosphamide / therapeutic use
  • Drug Combinations
  • Drug Interactions
  • Drug Therapy, Combination
  • Glomerulonephritis / drug therapy*
  • Glomerulonephritis / etiology
  • Glucaric Acid / adverse effects
  • Glucaric Acid / therapeutic use*
  • Gout / complications*
  • Gout Suppressants / adverse effects
  • Gout Suppressants / therapeutic use*
  • Hydrolases / adverse effects
  • Hydrolases / therapeutic use*
  • Hypocalcemia / chemically induced
  • Hypocalcemia / prevention & control
  • Hypokalemia / chemically induced
  • Hypokalemia / prevention & control
  • Male
  • Prednisolone / adverse effects
  • Prednisolone / therapeutic use
  • Rats
  • Rutin / adverse effects
  • Rutin / therapeutic use*

Substances

  • Drug Combinations
  • Gout Suppressants
  • Rutin
  • Allopurinol
  • Wobenzym
  • Cyclophosphamide
  • Prednisolone
  • Hydrolases
  • Glucaric Acid